SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-18-003115
Filing Date
2018-10-19
Accepted
2018-10-19 16:00:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 c92175_sc13g.htm SC 13G 96916
  Complete submission text file 0000930413-18-003115.txt   98396
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87623 | Film No.: 181130476
SIC: 2834 Pharmaceutical Preparations

Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G